NGM Biopharmaceuticals Inc (NASDAQ:NGM)
| 13.74 Delayed Data As of 4:00pm ET |  0.00 / 0.00%Today’s Change | 10.49 Today|||52-Week Range 27.25 | -22.42% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -6.9M | -14.2M | -493.0K | -- | |
| Depreciation | 3.5M | 6.4M | 7.2M | -- | ||
| Total Other Cash Flow | 7.2M | 8.0M | 7.1M | -- | ||
| Funds From Operations | 3.8M | 325.0K | 13.8M | -- | ||
| Funds From/For Other Operating Expenses | 2.5M | 17.7M | 23.6M | -- | ||
| Net Cash Flow - Operating Activities | 1.3M | -17.4M | -9.8M | -- | ||
| Investing | Increase In Investments | -132.6M | -217.3M | -133.6M | -- | |
| Decrease In Investments | 92.7M | 220.9M | 178.2M | -- | ||
| Capital Expenditures | -24.8M | -6.4M | -5.8M | -- | ||
| Net Cash Flow Investing | -64.7M | -2.8M | 38.7M | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Proceeds Stock Sale | 231.0K | 339.0K | 2.6M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | -185.0K | -- | ||
| Common Dividends | 0.00 | 0.00 | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Cash Flow - Financing | 231.0K | 339.0K | 2.4M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -63.2M | -19.9M | 31.3M | -- | ||
